APA (7th ed.) Citation

Umbreit, C., Erben, P., Lammert, A., Hofheinz, R., Aderhold, M. C., Weiß, C., . . . Schultz, J. D. (2015). MMP9, Cyclin D1 and β-Catenin are useful markers of p16-positive squamous cell carcinoma in therapeutic EGFR inhibition in vitro. Anticancer research, 35(7), .

Chicago Style (17th ed.) Citation

Umbreit, Claudia, Philipp Erben, Anne Lammert, Ralf-Dieter Hofheinz, Marc Christoph Aderhold, Christel Weiß, Karl Hörmann, Angela Schell, and Johannes D. Schultz. "MMP9, Cyclin D1 and β-Catenin Are Useful Markers of P16-positive Squamous Cell Carcinoma in Therapeutic EGFR Inhibition in Vitro." Anticancer Research 35, no. 7 (2015).

MLA (9th ed.) Citation

Umbreit, Claudia, et al. "MMP9, Cyclin D1 and β-Catenin Are Useful Markers of P16-positive Squamous Cell Carcinoma in Therapeutic EGFR Inhibition in Vitro." Anticancer Research, vol. 35, no. 7, 2015.